Please try another search
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1112 | 978 | 1228 | 873 | 1210 | - |
Fund Return | 11.19% | -2.21% | 22.78% | -4.41% | 3.88% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBAM Swiss Eq UD CHF | 1.76B | 11.68 | -4.01 | - | ||
UBAM Swiss Eq RC CHF | 1.76B | 10.43 | -5.30 | 4.83 | ||
UBAM Swiss Eq AHC CHF | 1.76B | 11.19 | -4.41 | - | ||
UBAM Swiss Eq IHC CHF | 1.76B | 11.56 | -4.03 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group NewPerspective lux Bh CHF | 15.69B | 0.85 | 0.49 | - | ||
Cap Group NewPerspective lux Zh CHF | 15.69B | 0.91 | 1.26 | - | ||
CapGroup NewPerspective lux ZLh CHF | 15.69B | 0.92 | 1.48 | - | ||
LU1201780084 | 24.88M | 1.21 | 5.75 | - | ||
Eleva Euro Slct Class R CHF H Acc | 6.34B | 8.85 | 4.58 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.54 | 91.93 | -1.87% | |
ABB | CH0012221716 | 7.23 | 49.96 | -0.40% | |
Roche Holding Participation | CH0012032048 | 6.72 | 253.50 | -0.31% | |
Nestle | CH0038863350 | 6.52 | 75.96 | -0.05% | |
UBS Group | CH0244767585 | 5.92 | 28.35 | +0.18% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review